Bayer to cut internal drug R&D work, axing hundreds of researchers while looking to partners as it unveils plan to slash 12,000 jobs
Bayer is pushing ahead with plans to restructure its drug R&D business and cut 900 research staffers as part of a broad plan to slash …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
